Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001104659-19-041307

10% owner bought 118,750 shares at $16.00 ($1,900,000)

  • 10% owner acquired 441,071 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
6 Dimensions Capital, L.P. 10% owner 2019-07-22 Conversion +441,071 441,071 D: show line 1 in the form
6 Dimensions Capital, L.P. 10% owner 2019-07-22 Purchase +118,750 $16.00 $1,900,000 559,821 D: show line 2 in the form
Open-market purchases · 118,750 sh · avg $16.00 · $1,900,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
6 Dimensions Capital, L.P. 10% owner 2019-07-22 Conversion · Series B Preferred Stock −3,087,500 0 D: show line 3 in the form
Loading xslF345X03/a4.xml…